Use of Molecular Imaging to Further Investigate PI-RADS 3 Lesions

被引：0
|
作者：
Turkbey, Baris [1 ]
机构：
[1] NCI, Mol Imaging Branch, Natl Inst Hlth, 10Ctr Dr,Room B3B85, Bethesda, MD 20892 USA
来源：
RADIOLOGY | 2024年 / 311卷 / 02期
关键词：
D O I：
10.1148/radiol.240401
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Efficacy of plasma atherogenic index in predicting malignancy in the presence of Prostate Imaging–Reporting and Data System 3 (PI-RADS 3) prostate lesions
    Samet Senel
    Kazim Ceviz
    Yusuf Kasap
    Sedat Tastemur
    Erkan Olcucuoglu
    Emre Uzun
    Muhammed Emin Polat
    Antonios Koudonas
    Firathan Sarialtin
    International Urology and Nephrology, 2023, 55 : 255 - 261
  • [32] PI-RADS 2.1 and structured reporting of magnetic resonance imaging of the prostate
    Hoetker, Andreas
    Donati, Olivio F.
    RADIOLOGE, 2021, 61 (09): : 802 - 809
  • [33] Gallium 68 PSMA-11 PET/CT Imaging in Patients with PI-RADS 3
    Yang, Jinhui
    Tang, Yongxiang
    Zhou, Chuanchi
    Hu, Shuo
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62
  • [34] Considering Predictive Factors in the Diagnosis of Clinically Significant Prostate Cancer in Patients with PI-RADS 3 Lesions
    Natale, Caleb
    Koller, Christopher R.
    Greenberg, Jacob W.
    Pincus, Joshua
    Krane, Louis S.
    LIFE-BASEL, 2021, 11 (12):
  • [35] Development and Validation of a Radiomics Nomogram for Predicting Clinically Significant Prostate Cancer in PI-RADS 3 Lesions
    Li, Tianping
    Sun, Linna
    Li, Qinghe
    Luo, Xunrong
    Luo, Mingfang
    Xie, Haizhu
    Wang, Peiyuan
    FRONTIERS IN ONCOLOGY, 2022, 11
  • [36] NECESSITY OF SYSTEMATIC BIOPSIES FOR PATIENTS WITH PI-RADS 5 LESIONS ON MULTIPARAMETRIC MRI
    Avda, Yuval
    Soodana-Prakash, Nachiketh
    Han, Sunwoo
    Reis, Isildinha
    Thomas, Jamie
    Ryan, Jonathan T.
    Nahar, Bruno
    Ritch, Chad R.
    Gonzalgo, Mark L.
    Parekh, Dipen J.
    Punnen, Sanoj
    JOURNAL OF UROLOGY, 2024, 211 (05): : E789 - E790
  • [37] IMPACT OF PI-RADS 5 LESIONS ON ACTIVE SURVEILLANCE FOR GRADE GROUP 1
    Sarah, Azari
    Bradley, Mason J.
    Alexander, Kenigsberg P.
    Christopher, Koller
    Sahil, Parikh
    William, Azar
    Kyle, Schuppe
    Jayant, Siva
    Charles, Hesswani
    Neil, Mendhiratta
    Daniel, Nethala
    Maria, Merino
    Bradford, Wood J.
    Peter, Choyke L.
    Howard, Parnes L.
    Sandeep, -Am
    Iris, Turkbey
    Peter, Pinto A.
    Howard, Parnes L.
    Sandeep, Gurram
    Iris, Turkbey
    Peter, Pinto A.
    Zoe, Blake
    Daniel, Nemirovsky R.
    Vladimir, Mezhiritsky
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2024, 42 : S95 - S95
  • [38] Prognostic significance of PI-RADS 5 lesions in patients treated by radical prostatectomy
    G. Fiard
    A. Seigneurin
    M. Roumiguié
    S. Albisinni
    J. Anract
    G. Assenmacher
    N. Barry Delongchamps
    C. Dariane
    A. Feyaerts
    A. Fourcade
    G. Fournier
    P. Gontero
    R. Mastroianni
    M. Oderda
    A. Peltier
    T. Roumeguère
    T. Saussez
    G. Simone
    J. Van Damme
    J. L. Descotes
    G. Ploussard
    R. Diamand
    World Journal of Urology, 2023, 41 : 1285 - 1291
  • [39] Machine Learning and Clinical-Radiological Characteristics for the Classification of Prostate Cancer in PI-RADS 3 Lesions
    Gravina, Michela
    Spirito, Lorenzo
    Celentano, Giuseppe
    Capece, Marco
    Creta, Massimiliano
    Califano, Gianluigi
    Ruvolo, Claudia Colla
    Morra, Simone
    Imbriaco, Massimo
    Di Bello, Francesco
    Sciuto, Antonio
    Cuocolo, Renato
    Napolitano, Luigi
    La Rocca, Roberto
    Mirone, Vincenzo
    Sansone, Carlo
    Longo, Nicola
    DIAGNOSTICS, 2022, 12 (07)
  • [40] Sub-differentiation of PI-RADS 3 lesions in TZ by advanced diffusion-weighted imaging to aid the biopsy decision process
    Zhou, Kun-Peng
    Huang, Hua-Bin
    Bu, Chao
    Luo, Zhong-Xing
    Huang, Wen-Sheng
    Xie, Li-Zhi
    Liu, Qing-Yu
    Bian, Jie
    FRONTIERS IN ONCOLOGY, 2023, 13
12345